0 Evaluaciones
ID

5056

Descripción

ODM derived from http://clinicaltrials.gov/show/NCT00968708

Link

http://clinicaltrials.gov/show/NCT00968708

Palabras clave

Versiones (2)
  1. 7/12/13 7/12/13 - Martin Dugas
  2. 17/4/14 17/4/14 - Julian Varghese
Subido en

17 de abril de 2014

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility NCT00968708 Diabetes Mellitus, Type 2

    Alemán Inglés

    Eligibility

    1 formularios  
    1. StudyEvent: Eligibility
      1. Eligibility
    Einschlusskriterien
    Descripción

    Einschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425202
    Alter mindestens 18 Jahre
    Descripción

    age at least 18 Years

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C0001779
    SNOMED CT 2011_0131
    397669002
    Diagnosis of type 2 diabetes mellitus
    Descripción

    Diagnosis of type 2 diabetes mellitus

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C0011860
    ICD-10-CM Version 2010
    E08-E13
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    Descripción

    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C0205171
    SNOMED CT 2011_0131
    50607009
    UMLS CUI 2011AA
    C0039798
    UMLS CUI 2011AA
    C0556895
    SNOMED CT 2011_0131
    229554006
    UMLS CUI 2011AA
    C0521124
    SNOMED CT 2011_0131
    65897001
    UMLS CUI 2011AA
    C0011849
    SNOMED CT 2011_0131
    191044006
    UMLS CUI 2011AA
    C1319284
    SNOMED CT 2011_0131
    408254005
    UMLS CUI 2011AA
    C1409616
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    Descripción

    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C0011900
    SNOMED CT 2011_0131
    439401001
    LOINC Version 232
    MTHU008876
    UMLS CUI 2011AA
    C0948089
    SNOMED CT 2011_0131
    394659003
    MedDRA 14.1
    10051592
    CTCAE 1105E
    E10066
    UMLS CUI 2011AA
    C0332152
    SNOMED CT 2011_0131
    288556008
    UMLS CUI 2011AA
    C0034656
    Ausschlusskriterien
    Descripción

    Ausschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425201
    Signs of type 1 diabetes mellitus
    Descripción

    Signs of type 1 diabetes mellitus

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C0011854
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    Descripción

    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756
    UMLS CUI 2011AA
    C0061355
    SNOMED CT 2011_0131
    43004008
    UMLS CUI 2011AA
    C0243071
    UMLS CUI 2011AA
    C0005802
    UMLS CUI 2011AA
    C2587213
    SNOMED CT 2011_0131
    31509003
    UMLS CUI 2011AA
    C0011860
    SNOMED CT 2011_0131
    44054006
    MedDRA 14.1
    10012613
    ICD-10-CM Version 2010
    E08-E13
    UMLS CUI 2011AA
    C1409616
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    Descripción

    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening

    Tipo de datos

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756
    UMLS CUI 2011AA
    C1827106
    SNOMED CT 2011_0131
    423837000
    Volver a la parte superior de la página

    Similar models

    Eligibility

    1 formularios
    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Einschlusskriterien
    CL425202 (UMLS CUI 2011AA)
    age at least 18 Years
    Item
    Alter mindestens 18 Jahre
    boolean
    C0001779 (UMLS CUI 2011AA)
    397669002 (SNOMED CT 2011_0131)
    Diagnosis of type 2 diabetes mellitus
    Item
    Diagnosis of type 2 diabetes mellitus
    boolean
    C0011860 (UMLS CUI 2011AA)
    E08-E13 (ICD-10-CM Version 2010)
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    Item
    Subject is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the subject's antidiabetic regimen includes insulin)
    boolean
    C0205171 (UMLS CUI 2011AA)
    50607009 (SNOMED CT 2011_0131)
    C0039798 (UMLS CUI 2011AA)
    C0556895 (UMLS CUI 2011AA)
    229554006 (SNOMED CT 2011_0131)
    C0521124 (UMLS CUI 2011AA)
    65897001 (SNOMED CT 2011_0131)
    C0011849 (UMLS CUI 2011AA)
    191044006 (SNOMED CT 2011_0131)
    C1319284 (UMLS CUI 2011AA)
    408254005 (SNOMED CT 2011_0131)
    C1409616 (UMLS CUI 2011AA)
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    Item
    Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization
    boolean
    C0011900 (UMLS CUI 2011AA)
    439401001 (SNOMED CT 2011_0131)
    MTHU008876 (LOINC Version 232)
    C0948089 (UMLS CUI 2011AA)
    394659003 (SNOMED CT 2011_0131)
    10051592 (MedDRA 14.1)
    E10066 (CTCAE 1105E)
    C0332152 (UMLS CUI 2011AA)
    288556008 (SNOMED CT 2011_0131)
    C0034656 (UMLS CUI 2011AA)
    Item Group
    Ausschlusskriterien
    CL425201 (UMLS CUI 2011AA)
    Signs of type 1 diabetes mellitus
    Item
    Signs of type 1 diabetes mellitus
    boolean
    C0011854 (UMLS CUI 2011AA)
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    Item
    Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
    boolean
    C1514756 (UMLS CUI 2011AA)
    C0061355 (UMLS CUI 2011AA)
    43004008 (SNOMED CT 2011_0131)
    C0243071 (UMLS CUI 2011AA)
    C0005802 (UMLS CUI 2011AA)
    C2587213 (UMLS CUI 2011AA)
    31509003 (SNOMED CT 2011_0131)
    C0011860 (UMLS CUI 2011AA)
    44054006 (SNOMED CT 2011_0131)
    10012613 (MedDRA 14.1)
    E08-E13 (ICD-10-CM Version 2010)
    C1409616 (UMLS CUI 2011AA)
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    Item
    Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening
    boolean
    C1514756 (UMLS CUI 2011AA)
    C1827106 (UMLS CUI 2011AA)
    423837000 (SNOMED CT 2011_0131)
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial